Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Suppression of intratumoral CCL22 by type i interferon inhibits migration of regulatory T cells and blocks cancer progression.
Anz D, Rapp M, Eiber S, Koelzer VH, Thaler R, Haubner S, Knott M, Nagel S, Golic M, Wiedemann GM, Bauernfeind F, Wurzenberger C, Hornung V, Scholz C, Mayr D, Rothenfusser S, Endres S, Bourquin C. Anz D, et al. Among authors: wiedemann gm. Cancer Res. 2015 Nov 1;75(21):4483-93. doi: 10.1158/0008-5472.CAN-14-3499. Epub 2015 Oct 2. Cancer Res. 2015. PMID: 26432403 Free article.
A novel TLR7 agonist reverses NK cell anergy and cures RMA-S lymphoma-bearing mice.
Wiedemann GM, Jacobi SJ, Chaloupka M, Krächan A, Hamm S, Strobl S, Baumgartner R, Rothenfusser S, Duewell P, Endres S, Kobold S. Wiedemann GM, et al. Oncoimmunology. 2016 May 31;5(7):e1189051. doi: 10.1080/2162402X.2016.1189051. eCollection 2016 Jul. Oncoimmunology. 2016. PMID: 27622045 Free PMC article.
Cancer cell-derived IL-1α induces CCL22 and the recruitment of regulatory T cells.
Wiedemann GM, Knott MM, Vetter VK, Rapp M, Haubner S, Fesseler J, Kühnemuth B, Layritz P, Thaler R, Kruger S, Ormanns S, Mayr D, Endres S, Anz D. Wiedemann GM, et al. Oncoimmunology. 2016 Apr 25;5(9):e1175794. doi: 10.1080/2162402X.2016.1175794. eCollection 2016. Oncoimmunology. 2016. PMID: 27757295 Free PMC article.
CCL1 is a major regulatory T cell attracting factor in human breast cancer.
Kuehnemuth B, Piseddu I, Wiedemann GM, Lauseker M, Kuhn C, Hofmann S, Schmoeckel E, Endres S, Mayr D, Jeschke U, Anz D. Kuehnemuth B, et al. Among authors: wiedemann gm. BMC Cancer. 2018 Dec 20;18(1):1278. doi: 10.1186/s12885-018-5117-8. BMC Cancer. 2018. PMID: 30572845 Free PMC article.
Constitutive Expression of CCL22 Is Mediated by T Cell-Derived GM-CSF.
Piseddu I, Röhrle N, Knott MML, Moder S, Eiber S, Schnell K, Vetter V, Meyer B, Layritz P, Kühnemuth B, Wiedemann GM, Gruen J, Perleberg C, Rapp M, Endres S, Anz D. Piseddu I, et al. Among authors: wiedemann gm. J Immunol. 2020 Oct 15;205(8):2056-2065. doi: 10.4049/jimmunol.2000004. Epub 2020 Sep 9. J Immunol. 2020. PMID: 32907996
Memory responses of innate lymphocytes and parallels with T cells.
Rapp M, Wiedemann GM, Sun JC. Rapp M, et al. Among authors: wiedemann gm. Semin Immunopathol. 2018 Jul;40(4):343-355. doi: 10.1007/s00281-018-0686-9. Epub 2018 May 28. Semin Immunopathol. 2018. PMID: 29808388 Free PMC article. Review.
17 results